#HT-001
August 20, 2026 at 12:25 PM
"Suicidality significantly declined from pretreatment to post-treatment ... ."

"These study findings provide clinical evidence supporting the mental health benefits of timely access to HT [hormone therapy] in this population."
August 17, 2026 at 7:05 PM
短すぎてタイトルに全部入っちゃいました! というわけで今週の #ごじチャン です。自由律の話から「俳句あれこれ」では、俳句か俳句じゃないかってどうやって決めてる? と投げかけております。みなさんのご意見、ご感想をお待ちしております!

#18 陽へ病む
stand.fm/episodes/6a0...
#18 陽へ病む - 俳句と暮らす ご自愛ラボチャンネル | stand.fm
【今週の一句】 陽へ病む 大橋裸木『昭和俳句作品年表 戦前・戦中篇』50頁 【今日の季語】 夏めく 【俳句あれこれ】 俳句か、俳句じゃないか 【参考】 きごさい歳時記 https://kigosai.sub.jp/001/ 角川学芸出版編『季寄せ』 感想、聞きたいことなどはレターまで! おたよりフォーム👇 ht...
stand.fm
May 15, 2026 at 11:03 PM
Parts 1-3/3 — EFTA01129027.jpg
#epsteinweb #efta01129027
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
May 10, 2026 at 9:26 AM
Hoth Therapeutics Gains Crucial Approval for Cancer Treatment in Spain with Promising Trial Results#Spain#Madrid#Hoth_Therapeutics#HT-001#EGFR_Inhibitor
Hoth Therapeutics Gains Crucial Approval for Cancer Treatment in Spain with Promising Trial Results
Hoth Therapeutics announces Spanish approval of its HT-001 clinical trial, showcasing promising efficacy for cancer patients experiencing skin toxicities.
third-news.com
May 5, 2026 at 8:28 PM
April 26, 2026 at 4:43 AM
Parts 1-3/3 — EFTA00124913.jpg
#epsteinweb #efta00124913
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
April 22, 2026 at 1:45 AM
April 10, 2026 at 12:31 PM
April 7, 2026 at 5:21 AM
April 5, 2026 at 4:57 PM
Hoth Therapeutics' HT-001 Scores Approval in Hungary After Successful Clinical Trial Phase#None#Clinical_Trials#Hoth_Therapeutics#HT-001
Hoth Therapeutics' HT-001 Scores Approval in Hungary After Successful Clinical Trial Phase
Hoth Therapeutics' HT-001 demonstrates promising clinical results, achieving key endpoints and gaining regulatory approval for trial expansion in Hungary, paving the way for broader patient enrollment.
third-news.com
April 1, 2026 at 12:51 PM
March 30, 2026 at 11:20 PM
Hoth Therapeutics Unveils Promising HT-001 Data for Cancer Patients with Skin Toxicities#United_States#New_York#Hoth_Therapeutics#HT-001#EGFR_Therapy
Hoth Therapeutics Unveils Promising HT-001 Data for Cancer Patients with Skin Toxicities
Hoth Therapeutics has announced remarkable results from the HT-001 study, showcasing improved drug exposure and safety for cancer patients suffering skin toxicities.
third-news.com
March 24, 2026 at 1:02 PM